LeMaitre Vascular (LMAT) to Release Earnings on Tuesday

LeMaitre Vascular (NASDAQ:LMAT) is set to issue its quarterly earnings data after the market closes on Tuesday, February 19th. Analysts expect the company to announce earnings of $0.24 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

NASDAQ:LMAT opened at $24.15 on Tuesday. The firm has a market capitalization of $465.66 million, a P/E ratio of 28.08, a P/E/G ratio of 2.70 and a beta of 1.05. LeMaitre Vascular has a 12-month low of $21.79 and a 12-month high of $41.28.

LMAT has been the subject of a number of recent research reports. BidaskClub upgraded LeMaitre Vascular from a “sell” rating to a “hold” rating in a report on Tuesday, October 30th. ValuEngine lowered LeMaitre Vascular from a “hold” rating to a “sell” rating in a report on Thursday, November 1st. Zacks Investment Research lowered LeMaitre Vascular from a “hold” rating to a “sell” rating in a report on Thursday, December 6th. Finally, Lake Street Capital reiterated a “hold” rating and issued a $24.00 target price on shares of LeMaitre Vascular in a report on Wednesday, January 23rd. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $32.86.

ILLEGAL ACTIVITY WARNING: This news story was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://transcriptdaily.com/2019/02/12/lemaitre-vascular-lmat-to-release-earnings-on-tuesday.html.

About LeMaitre Vascular

LeMaitre Vascular, Inc designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature.

Read More: How does a reverse stock split work?

Earnings History for LeMaitre Vascular (NASDAQ:LMAT)

Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply